“Clinical Efficacy of Rifampicin Nanoparticle Local Delivery in Post-Surgical Wound Infections Caused by Resistant Bacteria” (2025) Link Medical Journal, 3(2), pp. 1–11. doi:10.61919/xrpzj971.